252 related articles for article (PubMed ID: 30489610)
1. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.
Deák GG; Goldstein DA; Zhou M; Fawzi AA; Jampol LM
JAMA Ophthalmol; 2019 Feb; 137(2):194-198. PubMed ID: 30489610
[TBL] [Abstract][Full Text] [Related]
2. PERIVASCULAR FLOWER-BUD-LIKE LESIONS ON EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH VITREORETINAL LYMPHOMA.
Chen W; Gu J; Liu S; Zhao Z; Jiang T; Xu G; Chang Q
Retina; 2022 Nov; 42(11):2169-2175. PubMed ID: 35982514
[TBL] [Abstract][Full Text] [Related]
3. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
Maggio E; Bauci F; Polito A; Arena F; Pertile G
BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
[TBL] [Abstract][Full Text] [Related]
4. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
5. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
[TBL] [Abstract][Full Text] [Related]
6. Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma.
Keino H; Okada AA; Watanabe T; Echizen N; Inoue M; Takayama N; Nagane M
Ocul Immunol Inflamm; 2016 Jun; 24(3):268-73. PubMed ID: 25760916
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography manifestations of primary vitreoretinal lymphoma.
Saito T; Ohguro N; Iwahashi C; Hashida N
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2319-2326. PubMed ID: 27251192
[TBL] [Abstract][Full Text] [Related]
8. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma.
Pang CE; Shields CL; Jumper JM; Yannuzzi LA
Am J Ophthalmol; 2014 Dec; 158(6):1253-1261.e2. PubMed ID: 25174893
[TBL] [Abstract][Full Text] [Related]
10. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
[TBL] [Abstract][Full Text] [Related]
11. ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA.
Lavine JA; Singh AD; Sharma S; Baynes K; Lowder CY; Srivastava SK
Retina; 2019 Oct; 39(10):1861-1871. PubMed ID: 30044267
[TBL] [Abstract][Full Text] [Related]
12. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
13. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
14. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
15. En Face Optical Coherence Tomography Angiography of Primary Vitreoretinal Lymphoma.
Pierro L; Arrigo A; Casalino G; Miserocchi E; Aragona E; Bandello F
Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):e173-e174. PubMed ID: 30395684
[TBL] [Abstract][Full Text] [Related]
16. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
[TBL] [Abstract][Full Text] [Related]
17. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
18. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
19. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
20. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.
Cicinelli MV; Marchese A; Miserocchi E; Giuffré C; Berchicci L; Querques G; Bandello F; Modorati GM
Ocul Immunol Inflamm; 2020 May; 28(4):637-646. PubMed ID: 31393199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
